Intravitreal bevacizumab is not recommended for the treatment of new onset Nonarteritic Anterior Ischemic Optic Neuropathy (NAION).
News
Bausch + Lomb have signed a global agreement for the rights to distribute Leica's ophthalmic surgical microscopes.
Intravitreal bevacizumab is well tolerated and causes the regression of abnormal diabetic neovascularization, according to recently published data.
A new pressure-sensitive contact lens is tolerable and safe over a 24-hour wearing period for healthy subjects and glaucoma sufferers.
Multifocal diffractive add-on IOL is a suitable alternative to standard multifocal IOLs for sulcus fixation.
Unoprostone will begin patient enrolment for the Phase III clinical study for the treatment of retinitis pigmentosa (RP), claims the latest press release.
Undersized big-bubbles for DALK can safely be increased using blunt dissection for white-margin bubbles and ophthalmic viscosurgical device injection for clear-margin bubbles.
Low-fluence photodynamic therapy (PDT) decreases subfoveal choroidal thickness (SFCT) in central serous chorioretinopathy (CSC), states a paper in the journal Eye.
Small pupil size and short axial length predict good near vision after phacoemulsification and monofocal IOL implantation.
Trabectome, a device that ablates the arc of trabecular meshwork, is a safe and effective alternative to glaucoma surgery, according to a recent paper.
Ocular prosthesis wearers may require clinical assessment and management for meibomian gland dysfunction (MGD).
Multicomponent IOL implantation is safe, easy and provides excellent vision, according to a recent case series.
119th Congress of SFO will be held in Paris, France
Botulinum toxin type A (BTA) injections, with or without sodium hyaluronate (SH), are effective and feasible for the treatment of infantile esotropia.
Reading test results key is method to correct presbyopia in patients with emmetropia
Oral drug fenretinide has potential for the treatment of geographic atrophy (GA), but further studies are required.
Early reports on off-label uses for anti-VEGFs are promising
Tafluprost 0.0015% is safe, effective and well-tolerated in routine clinical practice
Catalys Precision Laser System features particularly beneficial for compromised cataract patients
Two-year results revealed of reading performance and patient satisfaction with KAMRA
A round-up of the latest ophthalmic products
Treating the aetiology of recurrent vitreous haemorrhage improves patient outcomes
Duration of disease should be considered when offering vein occlusion patient treatment
An overview of trials comparing topical medical therapies
Cost remains a large disadvantage to femtosecond laser cataract surgery
Early reports on off-label uses for anti-VEGFs are promising
First clinical results in the Eye Hospital Bellevue Kiel, Germany
Optimum centration of corneal inlays is vital for successful presbyopia correction
Even without refned nomograms, new-generation aberrometry is contributing to better results
Advertisement
Advertisement